Nolato AB

Chart & Performance

D1W1MN

P/E

33.81

P/S

1.54

EPS

1.61

Div Yield, %

3.48%

Shrs. gr., 5y

0.42%

Rev. gr., 5y

3.33%

Revenues

9.55b

-11.40%

Net income

435m

-37.59%

CFO

781m

+92.36%

Dividend

May 07, 20241.5 SEK/sh

Earnings

Feb 06, 2025

Profile

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products for medical technology, pharmaceutical, consumer electronics, telecom, automotive, and other industrial sectors in North America, Sweden, Asia, and other Europe region. The company offers consumables and reusable labware for clinical, chemical, forensic, research, and industrial testing laboratories; manufactures pipette tips, deep-well plates, microtubes, and PCR products; assemblies and post-processing services; and products for primary pharmaceutical packaging, as well as for solids, creams, and ophthalmic and customized production solutions. It designs, develops, and produces advanced components, subsystems, and ready-packaged electronics products, such as laser applications and ceramics, fitness trackers, loudspeaker systems, thermostats, webcams, and vaporiser heating products; automotive products; EMI shielding, thermal interface materials, and silicone sealing and damping solutions; and supplies plastic components and assemblies for food processing equipment, such as coffee machines and blenders. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was incorporated in 1938 and is headquartered in Torekov, Sweden.

URL

https://www.nolato.com/

IPO date

Jan 02, 1987

Employees

5,919

Domiciled in

Incorporated in

Valuation

Order:

Title SEK in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title SEK in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12	2014‑12
Income
Revenues	9,546,000 -11.40%	10,774,000 -7.20%	11,610,000 24.05%
Cost of revenue	9,445,000	10,624,000	11,079,000
Unusual Expense (Income)
NOPBT	101,000	150,000	531,000
NOPBT Margin	1.06%	1.39%	4.57%
Operating Taxes	181,000	178,000	241,000
Tax Rate	179.21%	118.67%	45.39%
NOPAT	(80,000)	(28,000)	290,000
Net income	435,000 -37.59%	697,000 -39.91%	1,160,000 43.92%
Dividends	(512,000)	(512,000)	(428,000)
Dividend yield	3.59%	3.48%	1.48%
Proceeds from repurchase of equity	8,000	8,000	100,000
BB yield	-0.06%	-0.05%	-0.34%
Debt
Debt current	117,000	224,000	160,000
Long-term debt	2,050,000	2,023,000	1,758,000
Deferred revenue			457,000
Other long-term liabilities	536,000	236,000	1,000
Net debt	1,476,000	1,233,000	466,000
Cash flow
Cash from operating activities	781,000	406,000	1,228,000
CAPEX	(426,000)	(455,000)	(782,000)
Cash from investing activities	(444,000)	(451,000)	(782,000)
Cash from financing activities	(631,000)	(487,000)	(634,000)
FCF	(362,000)	(959,000)	(212,000)
Balance
Cash	688,000	1,011,000	1,448,000
Long term investments	3,000	3,000	4,000
Excess cash	213,700	475,300	871,500
Stockholders' equity	4,683,000	4,904,000	4,280,000
Invested Capital	7,367,300	7,015,700	5,876,500
ROIC			5.27%
ROCE	1.33%	1.93%	7.58%
EV
Common stock shares outstanding	269,377	269,377	268,780
Price	52.90 -3.20%	54.65 -49.35%	107.90 29.69%
Market cap	14,250,048 -3.20%	14,721,458 -49.24%	29,001,310 30.77%
EV	15,726,048	15,954,458	29,467,310
EBITDA	697,000	694,000	1,003,000
EV/EBITDA	22.56	22.99	29.38
Interest	70,000	56,000	42,000
Interest/NOPBT	69.31%	37.33%	7.91%